CONTOLI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 11.974
AS - Asia 5.829
EU - Europa 3.887
SA - Sud America 1.051
AF - Africa 94
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 22.867
Nazione #
US - Stati Uniti d'America 11.745
SG - Singapore 2.549
CN - Cina 1.508
IT - Italia 1.013
BR - Brasile 866
DE - Germania 750
HK - Hong Kong 627
UA - Ucraina 488
VN - Vietnam 360
GB - Regno Unito 345
TR - Turchia 317
FI - Finlandia 306
SE - Svezia 227
PL - Polonia 193
RU - Federazione Russa 185
ID - Indonesia 156
MX - Messico 124
FR - Francia 108
CA - Canada 87
AR - Argentina 84
IN - India 80
NL - Olanda 71
JP - Giappone 52
BD - Bangladesh 50
ZA - Sudafrica 50
ES - Italia 39
LT - Lituania 30
AT - Austria 29
BE - Belgio 28
IQ - Iraq 26
PY - Paraguay 22
CZ - Repubblica Ceca 21
EC - Ecuador 20
AU - Australia 18
CO - Colombia 18
KR - Corea 18
UZ - Uzbekistan 12
PE - Perù 11
PK - Pakistan 11
VE - Venezuela 11
MA - Marocco 10
UY - Uruguay 9
CL - Cile 7
KE - Kenya 7
TN - Tunisia 7
AL - Albania 6
DZ - Algeria 6
JO - Giordania 6
NZ - Nuova Zelanda 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
HU - Ungheria 5
IR - Iran 5
TW - Taiwan 5
CH - Svizzera 4
EU - Europa 4
IE - Irlanda 4
MK - Macedonia 4
MY - Malesia 4
RO - Romania 4
RS - Serbia 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CR - Costa Rica 3
GE - Georgia 3
GY - Guiana 3
HR - Croazia 3
IL - Israele 3
KG - Kirghizistan 3
KH - Cambogia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
PT - Portogallo 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CG - Congo 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
SN - Senegal 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
DJ - Gibuti 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
Totale 22.853
Città #
Singapore 1.383
Fairfield 1.248
Ashburn 1.239
Woodbridge 1.044
Houston 969
Santa Clara 624
Hong Kong 623
Jacksonville 559
Chandler 537
Ann Arbor 508
Beijing 506
Seattle 494
Wilmington 493
Cambridge 427
Munich 376
Los Angeles 236
Dallas 203
Izmir 187
Ferrara 186
New York 186
Warsaw 180
Nanjing 177
Princeton 169
Milan 148
Jakarta 129
Ho Chi Minh City 123
Helsinki 122
San Diego 104
Chicago 93
Boardman 89
Shanghai 85
São Paulo 83
Mexico City 80
Hanoi 75
Addison 64
London 57
Turku 57
Dearborn 55
Nanchang 50
Rome 47
Shenyang 47
Tokyo 44
Tianjin 43
Hefei 42
Bologna 38
Buffalo 38
Brooklyn 37
Mountain View 35
Washington 35
The Dalles 33
Toronto 33
Atlanta 31
Changsha 31
Frankfurt am Main 31
Moscow 31
Hebei 30
Jiaxing 29
Boston 28
Redwood City 28
Council Bluffs 27
San Francisco 27
Brussels 26
Falls Church 26
Denver 25
Chennai 24
Nuremberg 24
Johannesburg 23
Montreal 23
Rio de Janeiro 23
Salt Lake City 23
Da Nang 22
Jinan 22
Norwalk 22
Orem 21
Phoenix 20
Amsterdam 19
Bremen 19
Columbus 19
Stockholm 19
Ankara 18
Guangzhou 18
Orange 18
Falkenstein 17
Dong Ket 16
Kunming 16
Lappeenranta 16
Poplar 16
Belo Horizonte 15
Brno 15
Manchester 15
Taizhou 15
Verona 15
Zhengzhou 15
Campinas 14
Gangbuk-gu 14
Brasília 13
Naples 13
Paris 13
Des Moines 12
Dhaka 12
Totale 15.449
Nome #
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 382
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 317
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 314
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 297
Targeting Th2 cells in asthmatic airways 276
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 264
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 257
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 237
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 230
Respiratory muscle training with normocapnic hyperpnea improves ventilatory pattern and thoracoabdominal coordination, and reduces oxygen desaturation during endurance exercise testing in COPD patients 227
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 224
The contribution of small-Airway abnormalities in chronic obstructive pulmonary disease clinical manifestations: More than a functional issue 218
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 214
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 204
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 204
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 198
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 197
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 193
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 188
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 188
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 186
Anti-SARS-Cov-2 IgA response in tears of COVID-19 patients 185
Physiologic Evaluation of Ventilation Perfusion Mismatch and Respiratory Mechanics at Different Positive End-expiratory Pressure in Patients Undergoing Protective One-lung Ventilation 181
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 178
A simple method for home exercise training in patients with chronic obstructive pulmonary disease: One-year study 173
Models of infection and exacerbations in COPD. 171
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 170
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 170
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 169
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 169
Is Peripheral Oxygen Saturation a Reliable Predictor of Upper Airways Air-Flow Limitation? 169
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 169
Rhinovirus vaccination: the case against 165
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 164
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 163
A serum proteome signature to predict mortality in severe COVID-19 patients 162
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 160
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 158
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 158
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 157
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 156
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 154
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 154
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 152
Cellule staminali e patologia polmonare dell’adulto 150
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 150
Asthma: A Chronic Infectious Disease? 146
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 143
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 143
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 143
Midazolam in flexible bronchoscopy premedication: effects on patient-related and procedure-related outcomes. 142
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 141
IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma 138
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 138
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 137
Interactions of airway pathogens and inflammatory processes 137
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 136
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): Focus on virus induced exacerbations 135
When asthma diagnosis becomes a challenge 134
ELEMENTI DI VALUTAZIONE E DIAGNOSTICA FUNZIONALE DELL’APPARATO RESPIRATORIO 133
A framework for step down or therapeutic re-organization for withdrawal of inhaled corticosteroids in selected patients with COPD: A proposal for COPD management 133
Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up 133
Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease 133
Models of respiratory infections: Virus-induced asthma exacerbations and beyond 132
Small airway disease in asthma: pathophysiological and diagnostic considerations 131
Bronchial epithelial cells from asthmatic children have a deficient innate immune response to rhinovirus infection 131
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy 129
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients 128
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses 127
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 127
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 127
Pathophysiology of viral-induced exacerbations of COPD 126
Mechanisms of respiratory virus-induced asthma exacerbations 126
Interleukin-4 Modulates Rhinovirus Replication and Antiviral Immune Response in Respiratory Epithelial Cells 126
null 126
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 125
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine 125
From intensive care to rehabilitation: survey on the satisfaction with care received during prolonged hospitalization for COVID-19 at a northern Italian university hospital 124
Do small airway abnormalities characterize asthma phenotypes? In search of proof. 124
Interactions of airway pathogens and inflammatory processes 124
Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease 123
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 123
Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study 123
Increased deposition of activated complement in peripheral lung vessels of smokers 122
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 122
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 121
Rhinovirus-induced bronchial mucosal inflammatory response in asthma 121
null 121
Deficient immune response to viral infections in children predicts later Asthma persistence 121
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 120
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 119
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 119
γδT cells suppress inflammation and disease during rhinovirus-induced asthma exacerbations. 119
Neutrophil adhesion molecules in experimental rhinovirus infection in COPD. 119
Disease awareness in patients with COPD: measurement and extent 119
Effects of Anti-IL-5 on Virus-induced Exacerbation in Asthma Light and Shadow 118
Rhinovirus-induced interferon production in asthma 117
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 117
Diffuse panbronchiolitis as parathymic syndrome in a Caucasian man previously treated for thymoma 117
Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands 115
Totale 16.021
Categoria #
all - tutte 121.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.849
Totale 125.429


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.382 0 0 0 0 0 181 103 261 74 305 266 192
2021/20221.529 74 125 108 140 56 80 85 98 65 116 160 422
2022/20231.438 185 62 69 145 205 192 107 117 174 26 104 52
2023/2024980 74 107 48 29 59 170 38 68 34 34 49 270
2024/20254.690 100 107 363 166 530 446 208 290 833 523 596 528
2025/20266.171 1.084 493 1.032 1.460 1.910 192 0 0 0 0 0 0
Totale 23.284